Related Experiment Videos

Degradation of cellular and viral Fos proteins

C Acquaviva1, P Ferrara, G Bossis

  • 1Institut de Génétique Moléculaire de Montpellier, UMR5535/IFR24, 1919, Montpellier, France.

Biochimie
|April 11, 2001
PubMed

Insights

The proteasome heavily degrades the oncogenic c-Fos protein, but its ubiquitinylation necessity for proteasomal targeting in vivo remains unclear. c-Fos and c-Jun degradation pathways differ, with viral Fos mutations impacting stability and oncogenicity.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • c-Fos proto-oncoprotein is a short-lived transcription factor with oncogenic potential.
  • Its degradation is primarily mediated by the proteasome, though other systems may play minor roles.
  • Ubiquitinylation's necessity for c-Fos proteasomal targeting in vivo is not definitively established.

Purpose of the Study:

  • To investigate the degradation mechanisms of c-Fos and its dimerization partner c-Jun.
  • To explore the role of ubiquitinylation in c-Fos proteasomal degradation.
  • To analyze the stability and oncogenic potential of mutated viral Fos proteins.

Main Methods:

  • Proteasome activity assays
  • Ubiquitinylation studies in vitro and in vivo
  • Analysis of mutated viral Fos proteins expressed in murine osteosarcoma models

Main Results:

  • c-Fos is extensively degraded by the proteasome in vivo.
  • c-Jun degradation is clearly proteasome- and ubiquitin-dependent.
  • Mutated viral Fos proteins exhibit altered stability and oncogenicity, with resistance to proteasomal degradation but sensitivity to other proteolytic systems.

Conclusions:

  • The degradation of AP-1 family members involves complex regulatory networks.
  • Distinct mechanisms govern the proteasomal targeting of c-Fos and c-Jun.
  • Viral Fos mutations modulate protein stability and oncogenicity, suggesting evolutionary control to prevent apoptosis.

Related Concept Videos